{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:46:28Z","timestamp":1786545988004,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Gastroenterol","Clinical and Translational Gastroenterology"],"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>We conducted a randomized, placebo-controlled trial, which evaluated a novel formulation of caraway oil and L-menthol using microsphere-based site-specific targeting (COLM-SST) vs placebo in patients with functional dyspepsia (FD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Adult men and women with FD defined by Rome III criteria were recruited. Patients were randomized to COLM-SST (25 mg of caraway oil and 20.75 mg of L-menthol per capsule, at 2 capsules per dose, twice per day) or placebo. Efficacy was measured at 24 hours, 2 weeks, and 4 weeks. Patients were allowed to take concomitant medications for their FD throughout the trial, and rescue medicines were allowed, 48 hours after start of dosing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Ninety-five patients were enrolled (mean age = 43.4 years; 75.8% women). At 24 hours, the active arm reported a statistically significant reduction in postprandial distress syndrome symptoms (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.039), and a nonsignificant trend toward benefit of epigastric pain syndrome symptoms (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.074). In patients with more severe symptoms, approximately 3 quarters of patients showed substantial global improvement (i.e., clinical global impressions), after 4 weeks of treatment, vs half in the control arm. These differences were statistically significant for patients with epigastric pain syndrome (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.046), and trending toward significance for patients with postprandial distress syndrome (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.091). There was no statistically significant difference between groups for Global Overall Symptom scores for the overall population at 2 and 4 weeks. Treatment emergent adverse events were mild to moderate, and no serious adverse events were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>In patients taking their usual medications for FD, COLM-SST provided rapid relief (within 24 hours) and relief of severe FD symptoms. It was safe and well tolerated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.14309\/ctg.0000000000000021","type":"journal-article","created":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T07:13:35Z","timestamp":1555139615000},"page":"e00021","source":"Crossref","is-referenced-by-count":31,"title":["A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial"],"prefix":"10.14309","volume":"10","author":[{"given":"William D.","family":"Chey","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, University of Michigan Health System, Ann Arbor, Michigan, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Lacy","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Mayo Clinic, Jacksonville, Florida, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks D.","family":"Cash","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, McGovern Medical School, University of Texas, Houston, Texas, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Epstein","sequence":"additional","affiliation":[{"name":"Digestive Disorders Associates, Annapolis, Maryland, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick E.","family":"Corsino","sequence":"additional","affiliation":[{"name":"IM Health Science, Boca Raton, Florida, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed M.","family":"Shah","sequence":"additional","affiliation":[{"name":"IM Health Science, Boca Raton, Florida, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"issue":"19","key":"R2-20230814","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMra1501505","article-title":"Functional dyspepsia","volume":"373","author":"Talley","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"R3-20230814","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2012.05128.x","article-title":"Review article: Current treatment options and management of functional dyspepsia","volume":"36","author":"Lacy","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"R4-20230814","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/1751-2980.12094","article-title":"A review of drug therapy for functional dyspepsia","volume":"14","author":"Chen","year":"2013","journal-title":"J Dig Dis"},{"issue":"3","key":"R5-20230814","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3923\/ijp.2006.309.315","article-title":"Effect of Carum carvi on experimentally induced gastric mucosal damage in Wistar albino rats","volume":"2","author":"Alhaider","year":"2006","journal-title":"Int J Pharmacol"},{"issue":"2","key":"R6-20230814","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cbi.2013.10.003","article-title":"Effect of menthol in experimentally induced ulcers: Pathways of gastroprotection","volume":"206","author":"Rozza","year":"2013","journal-title":"Chem Biol Interact"},{"issue":"1","key":"R7-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0086686","article-title":"The gastroprotective effect of menthol: Involvement of anti-apoptotic, antioxidant and anti-inflammatory activities","volume":"9","author":"Rozza","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"R8-20230814","first-page":"1","article-title":"Effects of Carum carvi L. (Caraway) extract and essential oil on TNBS-induced colitis in rats","volume":"8","author":"Keshavarz","year":"2013","journal-title":"Res Pharm Sci"},{"issue":"10","key":"R9-20230814","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.pain.2013.06.043","article-title":"TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain","volume":"154","author":"Liu","year":"2013","journal-title":"Pain"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/(SICI)1099-1573(200002)14:1<20::AID-PTR542>3.0.CO;2-Z","article-title":"Effects of peppermint oil and caraway oil on gastroduodenal motility","volume":"14","author":"Micklefield","year":"2000","journal-title":"Phyther Res"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ptr.1089","article-title":"Effects of intraduodenal application of peppermint oil (WS 1340) and caraway oil (WS 1520) on gastroduodenal motility in healthy volunteers","volume":"17","author":"Micklefield","year":"2003","journal-title":"Phyther Res"},{"issue":"12","key":"R12-20230814","first-page":"539","article-title":"The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: A novel perspective for its therapeutic use in inflammatory diseases","volume":"3","author":"Juergens","year":"1998","journal-title":"Eur J Med Res"},{"issue":"6","key":"R13-20230814","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/mi.2016.16","article-title":"Transient receptor potential melastatin 8 ion channel in macrophages modulates colitis through a balance-shift in TNF-alpha and interleukin-10 production","volume":"9","author":"Khalil","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"2","key":"R14-20230814","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00365520500206442","article-title":"A combination of peppermint oil and caraway oil attenuates the post-inflammatory visceral hyperalgesia in a rat model","volume":"41","author":"Adam","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1365-2036.2000.00873.x","article-title":"Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia","volume":"14","author":"May","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"R16-20230814","first-page":"319","article-title":"Treatment of functional dyspepsia with enteroplant: A multi-center randomized, double-blind, placebo-controlled, pilot phase II clinical trial","author":"Sun","year":"2016","journal-title":"Chin J Dig"},{"issue":"12","key":"R17-20230814","first-page":"1149","article-title":"Efficacy of a fixed peppermint oil\/caraway oil combination in non-ulcer dyspepsia","volume":"46","author":"May","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"e13132","DOI":"10.1111\/nmo.13132","article-title":"A randomized placebo-controlled trial on the effects of menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia","volume":"29","author":"K\u00f6hler","year":"2017","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"R19-20230814","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/gutjnl-2012-303857","article-title":"Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia","volume":"63","author":"Vanheel","year":"2014","journal-title":"Gut"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.3748\/wjg.14.2124","article-title":"Rome III: The Functional Gastrointestinal Disorders, third edition, 2006","volume":"14","author":"Mostafa","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"4","key":"R21-20230814","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2036.2006.02774.x","article-title":"Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials","volume":"23","author":"Veldhuyzen van Zanten","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"R22-20230814","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"R24-20230814","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5056\/jnm18060","article-title":"Role of the duodenum in the pathogenesis of functional dyspepsia: A paradigm shift","volume":"24","author":"Jung","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"issue":"1","key":"R25-20230814","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MCG.0000000000000740","article-title":"The role of duodenal inflammation in functional dyspepsia","volume":"51","author":"Walker","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"R26-20230814","first-page":"925","article-title":"Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride\u2014a multicenter, reference-controlled double-blind equivalence study","volume":"49","author":"Madisch","year":"1999","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"R27-20230814","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000076546","article-title":"Treatment of functional dyspepsia with a herbal preparation: A double-blind, randomized, placebo-controlled, multicenter trial","volume":"69","author":"Madisch","year":"2004","journal-title":"Digestion"},{"issue":"8","key":"R28-20230814","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.phymed.2004.10.005","article-title":"Peppermint oil in irritable bowel syndrome","volume":"12","author":"Grigoleit","year":"2005","journal-title":"Phytomedicine"},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1080\/14786419.2013.771350","article-title":"Extraction of the volatile oil from carum carvi of Tunisia and Lithuania by supercritical carbon dioxide: Chemical composition and antiulcerogenic activity","volume":"27","author":"Baananou","year":"2013","journal-title":"Nat Prod Res"}],"container-title":["Clinical and Translational Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01720094-201904000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:49:50Z","timestamp":1786542590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01720094-201904000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.14309\/ctg.0000000000000021","relation":{},"ISSN":["2155-384X"],"issn-type":[{"value":"2155-384X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]}}}